Hepatitis B vaccine

Journal of Pediatric Health Care

Volumn 13, Issue 5, 1999, Pages 211-216

  Ott, Mary Jane ^a,b   Aruda, Mary ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Andover Newton Theological School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; CHILD; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; INFORMATION SERVICE; INTERNET; METHODOLOGY; MORBIDITY; NURSING; PEDIATRIC NURSING; PRACTICE GUIDELINE; PRESCHOOL CHILD; REVIEW; RISK FACTOR; UNITED STATES; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFORMATION SERVICES; INTERNET; MORBIDITY; PEDIATRIC NURSING; PRACTICE GUIDELINES; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 0033185697     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5245(99)90001-9     Document Type: Article

References (20)

1. Alpér, C. A., Kruskall, M. S., Marcus-Bagley, D., Craven, D. E., Katz, A. J., Brink, S. T., Dienstag, J. L., Awdeh, Z., & Yunis, E. J. (1989). Genetic prediction of nonresponse to hepatitis B vaccine. New England Journal of Medicine, 321, 708-712.
2. American Academy of Pediatrics. (1992). Universal hepatitis B immunization. Pediatrics, 89, 795-800.
3. Anderson, H. G., & Visconti, J. A. (1996). Recombinant hepatitis B vaccines: A comparative review (pp. 14-20). In R. S. Koff (Ed.), Current strategies in the prevention of hepatitis B infection. Thorofare, NJ: Slack, Inc.
4. Andre, F. E. (1990). Summary of safety and efficacy data on a yeast derived hepatitis B vaccine. Hospital Formulary, 25(Suppl C), S26-S33.
5. Bloom, B. S., Hillman, A. L., Fendrick, M., & Schwartz, J. S. (1993). A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Annals of Internal Medicine, 118, 298-306.
6. Centers for Disease Control and Prevention. (1989). Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public safety workers. Morbidity and Mortality Weekly Report, 38 (S-6), 1-37.
7. Centers for Disease Control and Prevention. (1990). Protection against viral hepatitis: Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report, 39 (RR-2), 1-26.
8. Centers for Disease Control and Prevention (1991). Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morbidity and Mortality Weekly Report, 40 (RR-13), 1-25.
9. Centers for Disease Control and Prevention. (1994a). Standards for pediatric immunization practices. Atlanta, GA: Author.
10. Centers for Disease Control and Prevention. (1994b). Effectiveness in disease and injury prevention: Hepatitis B vaccination of adolescents - California, Louisiana, and Oregon, 1992-1994. Morbidity and Mortality Weekly Report, 43, 33, 605-609.
11. Committee on Infectious Diseases, American Academy of Pediatrics. (1997). Hepatitis B. In G. Peter (Ed.), Red Book 1997: Report of the Committee on Infectious Diseases (24th ed., pp. 247-260). Elk Grove Village, IL: Author.
12. Fishman, L. N., Jonas, M. M., & Lavine, J. E. (1996). Update on viral hepatitis in children. Pediatric Clinics of North America, 43, 57-74.
13. Kim S. C, Chung, E. K., Hodinka, R. L., DeMaio, J., West, D. J., Jawad, A. F., and Watson, B. (1997). Immunogenicity of hepatitis B vaccine in premature infants. Pediatrics, 99, 4, 534-536.
14. Lawrence, M. H., & Goldstein, M. A. (1995). Hepatitis B immunization in adolescents. Journal of Adolescent Health, 17, 234-243.
15. Merck & Co. (1996). Product information. Recombivax HB. West Point, PA: Merck & Co.
16. Merck & Co. (1996). Product information. Comvax. West Point, PA: Merck & Co.
17. Romero, R., & Lavine, J. (1994). Viral hepatitis in children. Seminars in Liver Disease, 14, 3, 289-302.
18. Santagostino, E., Mannucci, P. M., Gringeri, A., Rumi, M. G., Rafanelli, D., Rocino, A., Schiavoni, M., Chistolini, A., DiBona, E., & Muleo, G. (1993). Accelerated schedule of hepatitis B vaccination in patients with hemophilia. Journal of Medical Virology, 41, 95-98.
19. SmithKline Beecham Pharmaceuticals. (1994). Product information. Engerix-B. Philadelphia: SmithKline Beecham Pharmaceuticals.
20. Woodruff, B. A., Unti, L., Coyle, K., & Boyer-Chuanroong, L. (1996). Parents' attitudes toward school based hepatitis B vaccination of their children. Pediatrics, 98, 410-413.